Next report date
Report period
Q1 2024
EPS estimate
−0.59EUR
Revenue estimate
—
−2.4EUR
−392.16 MEUR
87.15 M
About Cerevel Therapeutics Holdings, Inc.
Sector
CEO
Ronald C. Renaud
Headquarters
Cambridge
Website
Employees (FY)
334
Founded
2018
FIGI
BBG01BV0JY77
Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CEREVEL THERAP.HLDGS stocks are traded under the ticker 673.
CEREVEL THERAP.HLDGS is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
673 earnings for the last quarter are −0.58 EUR per share, whereas the estimation was −0.59 EUR resulting in a 2.74% surprise. The estimated earnings for the next quarter are −0.61 EUR per share. See more details about CEREVEL THERAP.HLDGS earnings.
Yes, you can track CEREVEL THERAP.HLDGS financials in yearly and quarterly reports right on TradingView.
673 net income for the last quarter is −120.19 M EUR, while the quarter before that showed −91.16 M EUR of net income which accounts for −31.85% change. Track more CEREVEL THERAP.HLDGS financial stats to get the full picture.
No, 673 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 673 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CEREVEL THERAP.HLDGS stock right from TradingView charts — choose your broker and connect to your account.
As of May 4, 2024, the company has 334.00 employees. See our rating of the largest employees — is CEREVEL THERAP.HLDGS on this list?
We've gathered analysts' opinions on CEREVEL THERAP.HLDGS future price: according to them, 673 price has a max estimate of 41.98 EUR and a min estimate of 41.98 EUR. Watch 673 chart and read a more detailed CEREVEL THERAP.HLDGS stock forecast: see what analysts think of CEREVEL THERAP.HLDGS and suggest that you do with its stocks.